Top of the morning to you. And a fine morning it is. Lots of sunshine is enveloping the Pharmalot corporate campus, where we are scurrying to juggle various sundry tasks and prepare for assorted meetings and deadlines. There is always something to do, yes? So as you get ready to tackle your own agenda, please join us for that mandatory cup of stimulation. And, of course, here are some tidbits. Have a great day, everyone...
Par Pharmaceuticals Cuts 100 Jobs (Reuters)
Icahn Sues For Access To Forest CEO Records (Bloomberg News)
Johnson & Johnson Recalls More Extra Strength Tylenol (Associated Press)
Roche Loses UK Appeal Over Long-Term Tarceva Use (Reuters)
Biotechs And The New Normal (The Boston Globe)
Study Suggests Aspirin Interferes With AstraZeneca's Brilinta (Reuters)
Pfizer Submits Kidney Cancer Drug To FDA (Pharma Times)
Demolition Gets Under Way At Former Merck Plant (WALB)
Akrimax Sells Plant To Pfizer And 60 Jobs Are Lost (WCAX)
EDITOR’S NOTE: Please check this post for updates throughout the morning
steaming coffee thx to dleggett on flickr